美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=METFORMIN HYDROCHLORIDE"
符合检索条件的记录共 458 条
共 23 页，当前第 21 页
首页 上一页 下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 214494 002 ANDA METFORMIN HYDROCHLORIDE, SITAGLIPTIN TABLET, EXTENDED RELEASE 100MG No No 2026/03/10 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 214494 003 ANDA METFORMIN HYDROCHLORIDE, SITAGLIPTIN TABLET, EXTENDED RELEASE 50MG No No 2026/03/10 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 214494 004 ANDA METFORMIN HYDROCHLORIDE, SITAGLIPTIN TABLET, EXTENDED RELEASE 500MG No No 2026/03/10 (TA) -- APOTEX INC None (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 217829 002 ANDA SITAGLIPTIN, METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE 500MG No No 2026/03/25 (TA) -- INVENTIA HEALTHCARE LIMITED None (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 217829 003 ANDA SITAGLIPTIN, METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE 50MG No No 2026/03/25 (TA) -- INVENTIA HEALTHCARE LIMITED None (Tentative Approval)
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE 217829 004 ANDA SITAGLIPTIN, METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE 100MG No No 2026/03/25 (TA) -- INVENTIA HEALTHCARE LIMITED None (Tentative Approval)
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 001 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;500MG No No 2026/04/06 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 001 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;500MG No No 2026/04/06 (TA) 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 002 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;1GM No No 2026/04/06 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 002 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;1GM No No 2026/04/06 (TA) 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 003 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG;500MG No No 2026/04/06 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 003 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG;500MG No No 2026/04/06 (TA) 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 004 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG;1GM No No 2026/04/06 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211466 004 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG;1GM No No 2026/04/06 (TA) 2026/04/06 MICRO LABS Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211479 001 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;500MG No No 2026/04/06 2026/04/06 MSN Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211479 002 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;1GM No No 2026/04/06 2026/04/06 MSN Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211479 003 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG;500MG No No 2026/04/06 2026/04/06 MSN Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211479 004 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 10MG;1GM No No 2026/04/06 2026/04/06 MSN Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211489 001 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;500MG No No 2026/04/06 2026/04/06 AUROBINDO PHARMA Prescription
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 211489 002 ANDA DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL 5MG;1GM No No 2026/04/06 2026/04/06 AUROBINDO PHARMA Prescription
药品名称，活性成分，申请号搜索 高级检索
©2006-2026 DrugFuture->U.S. FDA Drugs Database